• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its...

cafead

Administrator
Staff member
  • cafead   Jun 26, 2023 at 08:52: PM
via After a $3.8 billion IPO, the J&J consumer-health business is leaning into communicating about its purpose and linking its new brand to its well-known products.

article source
 

<